New Data for Sacituzumab Govitecan-hziy in the Treatment of Metastatic Triple-Negative Breast Cancer

被引:0
作者
Bardia, Aditya [1 ,2 ]
机构
[1] Breast Canc Res Program, Boston, MA 02115 USA
[2] Harvard Med Sch, Med Oncol, Massachusetts Gen Hosp, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:723 / 725
页数:3
相关论文
共 50 条
[41]   Sacituzumab Govitecan as a Treatment Option for Patients with metastatic triple-negative Breast Cancer and impending Liver Failure: two Case Reports [J].
Wolf, E. E. ;
Agabejli, S. ;
Wimberger, P. ;
Link, T. .
GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (06) :E34-E34
[42]   Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan [J].
Valsecchi, Anna Amela ;
Pisegna, Simona ;
Antonuzzo, Andrea ;
Arpino, Grazia ;
Bianchini, Giampaolo ;
Biganzoli, Laura ;
Colloca, Giuseppe Ferdinando ;
Criscitiello, Carmen ;
Danesi, Romano ;
Fabi, Alessandra ;
Giusti, Raffaele ;
Pau, Loredana ;
Di Maio, Massimo ;
Santini, Daniele .
ONCOLOGIST, 2025, 30 (05)
[43]   Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer Comment [J].
Rozenblit, Mariya ;
Lustberg, Maryam B. .
ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (07)
[44]   Sacituzumab govitecan in Chinese patients with metastatic triple-negative breast cancer who received at least two prior treatments [J].
Xu, B. ;
Ma, F. ;
Wang, S. ;
Tong, Z. ;
Li, W. ;
Wu, X. ;
Wang, X. ;
Sun, T. ;
Pan, Y. ;
Yao, H. ;
Wang, X. ;
Luo, T. ;
Yang, J. ;
Zeng, X. ;
Zhao, W. ;
Cong, X. J. ;
Chen, J. .
ANNALS OF ONCOLOGY, 2022, 33 (07) :S650-S650
[45]   Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis [J].
Carey, Lisa A. ;
Loirat, Delphine ;
Punie, Kevin ;
Bardia, Aditya ;
Dieras, Veronique ;
Dalenc, Florence ;
Diamond, Jennifer R. ;
Fontaine, Christel ;
Wang, Grace ;
Rugo, Hope S. ;
Hurvitz, Sara A. ;
Kalinsky, Kevin ;
O'Shaughnessy, Joyce ;
Loibl, Sibylle ;
Gianni, Luca ;
Piccart, Martine ;
Zhu, Yanni ;
Delaney, Rosemary ;
Phan, See ;
Cortes, Javier .
NPJ BREAST CANCER, 2022, 8 (01)
[47]   Cost-effectiveness of sacituzumab govitecan versus chemotherapy in patients with relapsed or refractory metastatic triple-negative breast cancer [J].
Jiao Xie ;
SiNi Li ;
YaMin Li ;
JianHe Li .
BMC Health Services Research, 23
[48]   Sacituzumab Govitecan in Metastatic Breast Cancer [J].
Ganguly, Shuvadeep ;
Gogia, Ajay .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03)
[49]   Cost-effectiveness of sacituzumab govitecan versus chemotherapy in patients with relapsed or refractory metastatic triple-negative breast cancer [J].
Xie, Jiao ;
Li, SiNi ;
Li, YaMin ;
Li, JianHe .
BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
[50]   Efficacy of sacituzumab govitecan based regimen in triple-negative breast cancer: A systematic review. [J].
Khalid, Farhan ;
Kashyap, Richi ;
Singh, Vinit ;
Tayyeb, Muhammad ;
Jaan, Ali ;
Mohan, Gaurav ;
Meghal, Trishala .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)